Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Herstellerkennzeichnung
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
Cytogenetic Findings in Myeloproliferative Disorders.- Molecular Analyses of Chronic Myelocytic Leukemias.- Molecular Biological Investigation in Chronic Myelogenous Leukemia Patients Undergoing Interferon Therapie.- Effect of Recombinant Interferon-Alpha-2 on the Growth of Hematopoietic Progenitor Cells in Chronic Myelogenous Leukemia and Its Relationship to the Clinical Efficacy.- In Vitro Effects of Recombinant Human Tumor Necrosis Factor-Alpha and Interferon-Gamma on Normal and Leukemic Myelopoiesis.- Demonstration of Interferon-Alpha Receptors in Cultured Cell Lines and in Myeloid Cells from Patients with Acute or Chronic Myeloid Leukemia.- Differential Regulation of Cell Membrane Receptors for Interferon-Gamma and -Alpha on Peripheral Blood Cells of Patients with Chronic Myelogenous Leukemia During Interferon-Gamma/-Alpha Therapy.- Studies of Interferon as a Regulator on Hematopoietic Stem Cells in Chronic Myelogenous Leukemia.- Suppressive Effect of Interferon Alpha-2b on Hematopoietic Progenitor Cells in Patients with Chronic Myelogenous Leukemia.- Clinical Significance of Neutralizing Antibodies in Patients with Chronic Myelogenic Leukemia.- Cytostatic Therapy of Chronic Myelogenous Leukemia: Review and Perspectives.- In Vivo Effects of Interferon-gamma in Chronic Myelogenous Leukemia.- Treatment of Chronic and Acute Phase Chronic Myelogenous Leukemia with Interferon-Alpha-2b and Interferon-?.- Maintenance Therapy of Busulfan-Induced Chronic Granulocytic Leukemia Remissions with Interferon-Alpha-2b.- Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia.
Cytogenetic Findings in Myeloproliferative Disorders.- Molecular Analyses of Chronic Myelocytic Leukemias.- Molecular Biological Investigation in Chronic Myelogenous Leukemia Patients Undergoing Interferon Therapie.- Effect of Recombinant Interferon-Alpha-2 on the Growth of Hematopoietic Progenitor Cells in Chronic Myelogenous Leukemia and Its Relationship to the Clinical Efficacy.- In Vitro Effects of Recombinant Human Tumor Necrosis Factor-Alpha and Interferon-Gamma on Normal and Leukemic Myelopoiesis.- Demonstration of Interferon-Alpha Receptors in Cultured Cell Lines and in Myeloid Cells from Patients with Acute or Chronic Myeloid Leukemia.- Differential Regulation of Cell Membrane Receptors for Interferon-Gamma and -Alpha on Peripheral Blood Cells of Patients with Chronic Myelogenous Leukemia During Interferon-Gamma/-Alpha Therapy.- Studies of Interferon as a Regulator on Hematopoietic Stem Cells in Chronic Myelogenous Leukemia.- Suppressive Effect of Interferon Alpha-2b on Hematopoietic Progenitor Cells in Patients with Chronic Myelogenous Leukemia.- Clinical Significance of Neutralizing Antibodies in Patients with Chronic Myelogenic Leukemia.- Cytostatic Therapy of Chronic Myelogenous Leukemia: Review and Perspectives.- In Vivo Effects of Interferon-gamma in Chronic Myelogenous Leukemia.- Treatment of Chronic and Acute Phase Chronic Myelogenous Leukemia with Interferon-Alpha-2b and Interferon-?.- Maintenance Therapy of Busulfan-Induced Chronic Granulocytic Leukemia Remissions with Interferon-Alpha-2b.- Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
